As of November 14, 2026, Lipella Pharmaceuticals Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 4, 2026, naming 1 departure. The latest filing names Lori A. Birder, leaving (Form 8-K, February 4, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Lipella Pharmaceuticals Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Lipella Pharmaceuticals Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-04. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Lipella Pharmaceuticals Inc. files it.
Also on the record for Lipella Pharmaceuticals Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 1, 2025 | Form D, private offering | $9K sold | Form D page | Source |
| January 7, 2025 | Form D, private offering | $2.60M sold | Form D page | Source |
Selling to them or working with them? See who runs Lipella Pharmaceuticals Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Lipella Pharmaceuticals Inc. and the records around it.
Lipella Pharmaceuticals Inc. elsewhere on the record
- Form D filing Apr 2025
- Bankruptcy record
Watch Lipella Pharmaceuticals Inc.
Get an email when Lipella Pharmaceuticals Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Lipella Pharmaceuticals Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Lipella Pharmaceuticals Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lipella Pharmaceuticals Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-02-04 | Out | 8-K, 2026-02-04 |
Why did they leave? What the filings say
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Lori A. Birder (filed 2026-02-04):
Dr. Birder's decision to resign was not due to any disagreement with the Company on any matter relating to its operations, policies or practices.
New leaders reset buying decisions — get the Full Report on Lipella Pharmaceuticals Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Lipella Pharmaceuticals Inc., with the record behind each one.
Find candidates like senior executive at Lipella Pharmaceuticals Inc.Every change, in the filing's words
Departing: Lori A. Birder
On February 3, 2026, Lori A. Birder notified Lipella Pharmaceuticals Inc. (the "Company") of her resignation from the Company's Board of Directors, effective immediately.
Tools for this story
Each opens in a new tab, filled in for Lipella Pharmaceuticals Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
